1. Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson’s disease in Taiwan
- Author
-
Ying-Zu Huang, Rou-Shayn Chen, Yah Huei Wu-Chou, Hsiu Chen Chang, Chia Ling Huang, Szu-Chia Lai, Yi H. Weng, Tu Hsueh Yeh, and Chin-Song Lu
- Subjects
Genetics ,Oncology ,medicine.medical_specialty ,business.industry ,Parkinsonism ,Case-control study ,medicine.disease ,LRRK2 ,Neurology ,Internal medicine ,Genotype ,Mutation (genetic algorithm) ,medicine ,Neurology (clinical) ,Age of onset ,Allele ,business ,Glucocerebrosidase - Abstract
Background and purpose: The association between glucocerebrosidase (GBA) mutations and Parkinson’s disease (PD) is attracting increased attention worldwide. In patients of Chinese ethnicity, other than the common L444P mutation, a few mutations have been reported. However, the contribution of GBA to PD can be answered only by a thorough investigation of its mutations in a unique large population. Methods: We enrolled 1747 participants: 967 PD patients and 780 healthy individuals. We screened entire GBA coding regions and exon–intron boundaries in 30 randomly chosen PD patients, followed by testing five variants (L444P, D409H, R120W, L174P, and Q497R) in all participants. The G2385R and R1628P in LRRK2 had been previously studied in almost all participants. Results: In total, 36 patients (3.72%) carried a heterozygous mutant GBA allele (27 L444P, 7 RecNciI, and 2 D409H). Only two controls (0.26%) carried heterozygous GBA mutation (1 L444P and 1 RecNciI). In PD group, the mean age at onset in carriers was younger than in non-carriers. The difference in percentage of mutation frequencies between patients and controls was highly significant for the L444P mutation (P
- Published
- 2011
- Full Text
- View/download PDF